Coriolis Pharma

Advanced-therapyAccepting projects

Accelerating your drug's development

Martinsried, GermanyEurope2 sitesEst. 2008 · 18yWebsite

Request a proposal Post a project Open roomCompare

Overview Capabilities Capability matrix Technologies Regulatory & quality Project history Scientific team

Capabilities & focus

Process-development services

Formulation developmentAnalytical method developmentStability testingLyophilization cycle development

Molecule types

Monoclonal antibodyRecombinant proteinPeptideViral vector (AAV/LV)

Formulation

High-concentration mAbLyophilization

Technology platforms

Not a platform licensor. Stated capabilities include 200+ analytical devices with an analytical ultracentrifugation (AUC) capabilitya Lyophilization Centeran HPLC Centera Particle Identification Centera Center for Cell Culturean automated filling line and manual filling under aseptic conditionsand 200 analytical methods in-house.

COR

Coriolis Pharma

Process development org · Germany

Post a project Request a proposal

Live record · illustrative seed data · scores deterministic, rules-based — not AI. Not a regulatory determination or endorsement.